SIRT1 contributes to neuroendocrine differentiation of prostate cancer

被引:25
|
作者
Ruan, Lin [1 ,2 ]
Wang, Lei [3 ]
Wang, Xiaosong [1 ,4 ]
He, Ming [1 ,4 ]
Yao, Xiaoguang [1 ,4 ]
机构
[1] Hebei Univ Chinese Med, Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Nephrol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Dept Urol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Univ Chinese Med, Coll Integrat Med, Shijiazhuang, Hebei, Peoples R China
关键词
prostate cancer; SIRT1; neuroendocrine; N-Myc; Akt; OXIDATIVE STRESS; CELL-SURVIVAL; RESISTANT; EXPRESSION; P53; PROMOTES; MODULATION; APOPTOSIS; AUTOPHAGY; GENOMICS;
D O I
10.18632/oncotarget.23111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epigenetic factor SIRT1 can promote prostate cancer progression, but it is unclear whether SIRT1 contributes to neuroendocrine differentiation. In this study, we showed that androgen deprivation can induce reactive oxygen species production and that reactive oxygen species, in turn, activate SIRT1 expression. The increased SIRT1 expression induces neuroendocrine differentiation of prostate cancer cells by activating the Akt pathway. In addition, the interaction between Akt and SIRT1 is independent of N-Myc and can drive the development of neuroendocrine prostate cancer when N-Myc is blocked. Furthermore, SIRT1 facilitates tumor maintenance, and targeting SIRT1 may reduce the tumor burden during androgen deprivation. Our findings suggest that SIRT1 is a potential target for therapeutic intervention.
引用
收藏
页码:2002 / 2016
页数:15
相关论文
共 50 条
  • [41] SIRT1 siRNA-loaded lipid nanoparticles enhanced doxorubicin-induced cell death in prostate cancer cell lines
    Debelec-Butuner, Bilge
    Oner, Ezgi
    Kotmakci, Mustafa
    Kantarci, Ayse Gulten
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 66
  • [42] The critical role of Sirt1 in ischemic stroke
    Jia, Ziyi
    Xu, Ke
    Li, Ruobing
    Yang, Siyu
    Chen, Long
    Zhang, Qianwen
    Li, Shulin
    Sun, Xiaowei
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [43] Prognostic Role of SIRT1 in Hepatocellular Carcinoma
    Song, Shijun
    Luo, Min
    Song, Yan
    Liu, Tianji
    Zhang, Haishan
    Xie, Zhongshi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (11): : 849 - 854
  • [44] The Critical Role of Sirt1 in Subarachnoid Hemorrhages: Mechanism and Therapeutic Considerations
    Zhang, Zhonghua
    Liu, Cong
    Zhou, Xiaoming
    Zhang, Xin
    BRAIN SCIENCES, 2023, 13 (04)
  • [45] Distribution of the longevity gene product, SIRT1, in developing mouse organs
    Ogawa, Tetsuo
    Wakai, Chizu
    Saito, Tomomi
    Murayama, Aya
    Mimura, Yuuichi
    Youfu, Sachiko
    Nakamachi, Tomoya
    Kuwagata, Makiko
    Satoh, Kazue
    Shioda, Seiji
    CONGENITAL ANOMALIES, 2011, 51 (02) : 70 - 79
  • [46] SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression
    Huang, Shih-Bo
    Rivas, Paul
    Yang, Xiaoyu
    Lai, Zhao
    Chen, Yidong
    Schadler, Keri L.
    Hu, Ming
    Reddick, Robert L.
    Ghosh, Rita
    Kumar, Addanki P.
    MOLECULAR CARCINOGENESIS, 2022, 61 (07) : 702 - 716
  • [47] The role of miR-141/Sirt1 in colon cancer
    Li, Yongliang
    Gu, Feiteng
    Lin, Xi
    JOURNAL OF BUON, 2020, 25 (06): : 2665 - 2671
  • [48] Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
    Puca, Loredana
    Vlachostergios, Panagiotis J.
    Beltran, Himisha
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (02):
  • [49] Cellular Regulation of SIRT1
    Milner, Jo
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (01) : 39 - 44
  • [50] Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells
    Courel, Maite
    El Yamani, Fatima-Zohra
    Alexandre, David
    El Fatemi, Hinde
    Delestre, Charlene
    Montero-Hadjadje, Maite
    Tazi, Fadl
    Amarti, Afaf
    Magoul, Rabia
    Chartrel, Nicolas
    Anouar, Youssef
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (17) : 3039 - 3049